Aug. 27: Better HIV Treatment Response Seen in Older Patients
	People who become infected with HIV after the age of 30 have a better response to antiretroviral (ARV) therapy than people who become infected at a younger age, according to a study published in the September 1 issue of the Journal of Acquired Immune Deficiency Syndromes.

	Aug. 25: Cases of HIV Detectable in Semen, but Not Blood
	Five percent of HIV-positive men in a French study had detectable HIV in their semen even when no HIV was detectable in their blood, say the authors of a study published in the August 20 issue of AIDS.

	Aug. 22: New Drug Interaction Information With Reyataz
	The U.S. Food and Drug Administration (FDA) issued new instructions on potential drug interactions between the protease inhibitor Reyataz (atazanavir) and several other types of medications, including antiretroviral drugs, hormonal contraceptives and stomach acid reducers.

	Aug. 22: Non-Nukes and Triglyceride Levels Affect HDL Cholesterol
	Having an undetectable viral load and taking a regimen including a non-nucleoside reverse transcriptase inhibitor (NNRTI) may protect against unhealthy reductions in “good” HDL cholesterol, according to a study published in the July issue of AIDS Patient Care and STDs.

	Aug. 21: Short-term Therapy May Help HIV-Related Depression
	A short 20-week course of psychotherapy may improve depression and anxiety symptoms for gay men living with HIV, according to a study in the July issue of AIDS Patient Care and STDs.